Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vanja, Nikic"'
Autor:
Javier Díez-Domingo, Xavier Sáez-Llorens, Miguel A Rodriguez-Weber, Cristina Epalza, Archana Chatterjee, Cheng-Hsun Chiu, Chien-Yu Lin, Andrea A Berry, Federico Martinón-Torres, Fernando Baquero-Artigao, Joanne M Langley, José T Ramos Amador, Joseph B Domachowske, Li-Min Huang, Nan-Chang Chiu, Susanna Esposito, Philippe Moris, Thi Lien-Anh Nguyen, Vanja Nikic, Wayne Woo, Yingjun Zhou, Ilse Dieussaert, Amanda Leach, Antonio Gonzalez Lopez, Nicolas Vanhoutte
Publikováno v:
The Journal of Infectious Diseases. 227:1293-1302
Background Safe and effective respiratory syncytial virus (RSV) vaccines remain elusive. This was a phase I/II trial (NCT02927873) of ChAd155-RSV, an investigational chimpanzee adenovirus-RSV vaccine expressing 3 proteins (fusion, nucleoprotein, and
Autor:
Javier, Díez-Domingo, Xavier, Sáez-Llorens, Miguel A, Rodriguez-Weber, Cristina, Epalza, Archana, Chatterjee, Cheng-Hsun, Chiu, Chien-Yu, Lin, Andrea A, Berry, Federico, Martinón-Torres, Fernando, Baquero-Artigao, Joanne M, Langley, José T, Ramos Amador, Joseph B, Domachowske, Li-Min, Huang, Nan-Chang, Chiu, Susanna, Esposito, Philippe, Moris, Thi Lien-Anh, Nguyen, Vanja, Nikic, Wayne, Woo, Yingjun, Zhou, Ilse, Dieussaert, Amanda, Leach, Antonio, Gonzalez Lopez, Nicolas, Vanhoutte
Publikováno v:
The Journal of infectious diseases.
Safe and effective respiratory syncytial virus (RSV) vaccines remain elusive. This was a phase I/II trial (NCT02927873) of ChAd155-RSV, an investigational chimpanzee adenovirus-RSV vaccine expressing the F-, N- and M2-1 proteins, administered to 12-2